Supplemental Materials for Joseph Merola et al. Efficacy And Safety Of Apremilast In Patients With Moderate-To-Severe Genital Psoriasis: Results From Discreet, A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Published: 13 October 2023| Version 2 | DOI: 10.17632/dhtrp945bn.2
Contributors:
Joseph Merola, Lawrence C Parish, Charles Lynde, Lyn Guenther, Jean-Philippe Lacour, Petra Staubach, Sue Cheng, Maria Paris, Hernan Picard, Cynthia Deignan, Shauna Jardon, Mindy Chen, Kim Papp

Description

Mendeley Supplemental Figures for Joseph Merola et al. Efficacy And Safety Of Apremilast In Patients With Moderate-To-Severe Genital Psoriasis: Results From Discreet, A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial. J Am Acad Dermatol. 2023.

Files

Categories

Clinical Trial, Safety, Therapeutics, Controlled Clinical Trial, Psoriasis, Quality of Life

Licence